Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
Dartmouth-Hitchcock Medical Center
Novartis
Guangdong Second Provincial General Hospital
Amgen
Roswell Park Cancer Institute
Stanford University
Abramson Cancer Center at Penn Medicine
Washington University School of Medicine
University of Nebraska
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Fudan University
Amgen
Singapore General Hospital
Greenwich LifeSciences, Inc.
City of Hope Medical Center
Allogene Therapeutics
Medical College of Wisconsin
Second Xiangya Hospital of Central South University
H. Lee Moffitt Cancer Center and Research Institute
MedSIR
University of Oklahoma
PETHEMA Foundation
Peking University People's Hospital
Sun Yat-sen University
Institute of Hematology & Blood Diseases Hospital, China
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Columbia University
University of Chicago
Tongji Hospital
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Alabama at Birmingham
Centre Henri Becquerel
Fondazione Italiana Linfomi - ETS
Ruijin Hospital
Peking University People's Hospital
Nanfang Hospital, Southern Medical University
Shanghai Zhongshan Hospital
Centre Jean Perrin
French Innovative Leukemia Organisation
Assistance Publique - Hôpitaux de Paris
Stanford University
Fred Hutchinson Cancer Center
Baylor College of Medicine
University of Rochester